Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP50589.RAA7JakrXZ6ZqgH3-O-k9ZcCLnE5TEs6lhfg8xFpj-hVA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP50589.RAA7JakrXZ6ZqgH3-O-k9ZcCLnE5TEs6lhfg8xFpj-hVA130_assertion type Assertion NP50589.RAA7JakrXZ6ZqgH3-O-k9ZcCLnE5TEs6lhfg8xFpj-hVA130_head.
- NP50589.RAA7JakrXZ6ZqgH3-O-k9ZcCLnE5TEs6lhfg8xFpj-hVA130_assertion description "[The polymorphic status of MRP2 C-24T and GSTP1 Ile105Val might be the predictive markers for the treatment response of advanced NSCLC patients. The DNA microarray-based method is accurate, high throughput and inexpensive, suitable for single-nucleotide po]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50589.RAA7JakrXZ6ZqgH3-O-k9ZcCLnE5TEs6lhfg8xFpj-hVA130_provenance.
- NP50589.RAA7JakrXZ6ZqgH3-O-k9ZcCLnE5TEs6lhfg8xFpj-hVA130_assertion evidence source_evidence_literature NP50589.RAA7JakrXZ6ZqgH3-O-k9ZcCLnE5TEs6lhfg8xFpj-hVA130_provenance.
- NP50589.RAA7JakrXZ6ZqgH3-O-k9ZcCLnE5TEs6lhfg8xFpj-hVA130_assertion SIO_000772 19568750 NP50589.RAA7JakrXZ6ZqgH3-O-k9ZcCLnE5TEs6lhfg8xFpj-hVA130_provenance.
- NP50589.RAA7JakrXZ6ZqgH3-O-k9ZcCLnE5TEs6lhfg8xFpj-hVA130_assertion wasDerivedFrom gad-20150221 NP50589.RAA7JakrXZ6ZqgH3-O-k9ZcCLnE5TEs6lhfg8xFpj-hVA130_provenance.
- NP50589.RAA7JakrXZ6ZqgH3-O-k9ZcCLnE5TEs6lhfg8xFpj-hVA130_assertion wasGeneratedBy ECO_0000203 NP50589.RAA7JakrXZ6ZqgH3-O-k9ZcCLnE5TEs6lhfg8xFpj-hVA130_provenance.